Armistice Capital, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 6,400 shares at $4.13 ($27K) on 2020-12-04, disclosed to the SEC on 2020-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 1,000 | $4K | 16.2% |
| 2 | $4.13 | 5,400 | $22K | 83.8% |
| Total | $4.16 avg | 6,400 | $27K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |